Nigel Gay

6.0k total citations
62 papers, 4.1k citations indexed

About

Nigel Gay is a scholar working on Epidemiology, Health and Modeling and Simulation. According to data from OpenAlex, Nigel Gay has authored 62 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Epidemiology, 19 papers in Health and 13 papers in Modeling and Simulation. Recurrent topics in Nigel Gay's work include Virology and Viral Diseases (22 papers), Vaccine Coverage and Hesitancy (19 papers) and COVID-19 epidemiological studies (13 papers). Nigel Gay is often cited by papers focused on Virology and Viral Diseases (22 papers), Vaccine Coverage and Hesitancy (19 papers) and COVID-19 epidemiological studies (13 papers). Nigel Gay collaborates with scholars based in United Kingdom, Italy and Canada. Nigel Gay's co-authors include Alessia Melegaro, W. John Edmunds, W. John Edmunds, Gaston De Serres, Elizabeth Miller, Marc Brisson, Richard Pitman, Caroline Trotter, P Morgan-Capner and B Law and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Nigel Gay

62 papers receiving 3.9k citations

Peers

Nigel Gay
Comparison fields: 5 of 132
  • Epidemiology 3.1k
  • Modeling and Simulation 841
  • Infectious Diseases 786
  • Microbiology 675
  • Health 664
Ismael R. Ortega‐Sanchez United States
Marc Brisson Canada
Albert Jan van Hoek United Kingdom
Alessia Melegaro Italy
Paul Gargiullo United States
Fiona van der Klis Netherlands
Heath Kelly Australia
Antonino Bella Italy
D. James Nokes United Kingdom
Paolo Bonanni Italy
Ismael R. Ortega‐Sanchez United States View profile →
Citations per field, relative to Nigel Gay
Nigel Gay · 1×
Citations per year, relative to Nigel Gay
Nigel Gay · 1×

Countries citing papers authored by Nigel Gay

Since Specialization
Citations

This map shows the geographic impact of Nigel Gay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Gay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Gay more than expected).

Fields of papers citing papers by Nigel Gay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel Gay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Gay. The network helps show where Nigel Gay may publish in the future.

Co-authorship network of co-authors of Nigel Gay

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel Gay. A scholar is included among the top collaborators of Nigel Gay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel Gay. Nigel Gay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Reconstructing a spatially heterogeneous epidemic: Characterising the geographic spread of 2009 A/H1N1pdm infection in England Scientific Reports Paul Birrell, Xu‐Sheng Zhang et al. 7
2 Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: Quantification using a multi-type mathematical model Vaccine Yoon Hong Choi, Ruth Chapman et al. 19
3 Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England Vaccine Albert Jan van Hoek, Alessia Melegaro et al. 93
4 7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement? PLoS ONE Yoon Hong Choi, Mark Jit et al. 49
5 The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom Vaccine Albert Jan van Hoek, Alessia Melegaro et al. 60
6 Pneumococcal Carriage in United Kingdom Families: Estimating Serotype-specific Transmission Parameters from Longitudinal Data American Journal of Epidemiology Alessia Melegaro, Yoon Hong Choi et al. 57
7 Assessing the burden of influenza and other respiratory infections in England and Wales Journal of Infection Richard Pitman, Alessia Melegaro et al. 130
8 Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination American Journal of Epidemiology Caroline Trotter, Nigel Gay et al. 139
9 The natural history of meningococcal carriage and disease Epidemiology and Infection Caroline Trotter, Nigel Gay et al. 93
10 Estimating the transmission parameters of pneumococcal carriage in households Epidemiology and Infection Alessia Melegaro, Nigel Gay et al. 107
11 Economic evaluation of options for measles vaccination strategy in a hypothetical Western European country Epidemiology and Infection Philippe Beutels, Nigel Gay 21
12 Analysis of longitudinal bacterial carriage studies accounting for sensitivity of swabbing: an application to Neisseria meningitidis Epidemiology and Infection Caroline Trotter, Nigel Gay 19
13 Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995–March 1998 Epidemiology and Infection Berit Müller‐Pebody, W. John Edmunds et al. 68
14 The Prevalence of Hepatitis C in England and Wales Journal of Infection Mary Ramsay, Louise Hesketh et al. 42
15 The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales Vaccine W. John Edmunds, Marc Brisson et al. 72
16 Ten years of serological surveillance in England and Wales: methods, results, implications and action International Journal of Epidemiology K Osborne, Nigel Gay et al. 99
17 Control of hepatitis B in the United Kingdom Vaccine Mary Ramsay, Nigel Gay et al. 35
18 Modelling the incidence of measles in Canada: an assessment of the options for vaccination policy Vaccine Nigel Gay, Louise Pelletier et al. 25
19 Hospital Admissions Attributable To Rotavirus Infection In England And Wales The Journal of Infectious Diseases Marie Ryan, Mary Ramsay et al. 164
20 Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options Epidemiology and Infection D. James Nokes, Nigel Gay et al. 87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ismael R. Ortega‐Sanchez Breakdown of academic impact, for papers by Marc Brisson Breakdown of academic impact, for papers by Albert Jan van Hoek Breakdown of academic impact, for papers by Alessia Melegaro Breakdown of academic impact, for papers by Paul Gargiullo Breakdown of academic impact, for papers by Fiona van der Klis Breakdown of academic impact, for papers by Heath Kelly Breakdown of academic impact, for papers by Antonino Bella Breakdown of academic impact, for papers by D. James Nokes Breakdown of academic impact, for papers by Paolo Bonanni
Rankless by CCL
2026